(Candida albicans Skin Test Antigen for Cellular Immunity)
CANDIN is the only Candida albicans extract-based skin testing antigen for intradermal injection licensed by the FDA to assess cell-mediated hypersensitivity to Candida albicans.
CANDIN should not be used to diagnose or treat Type 1 allergy to Candida albicans.
Important Safety Information Full Prescribing Information Safety Data Sheet
Every lot of CANDIN is tested in a clinical trial for consistency of potency.
CANDIN has demonstrated consistent clinical potency over its history.
CANDIN may be useful in evaluating patients suspected of having a reduced cellular immune response in patients that respond to candida antigen.
Because some persons with normal cellular immunity are not hypersensitive to Candida (see below), concurrent use of other cell-mediated hypersensitivity skin testing antigens is recommended.
Are you positive they’re negative?
CANDIN is cited as a control for tuberculin skin testing (TST) to rule out anergy as a possible factor in persons who are skin-test negative to tuberculin.
Ann Pharmacother. 2004 Jun;38(6):973-7. Epub 2004 Apr 14.
J Rheumatol. 2008 May;35(5):770-5.